BioSpace News Archive

Business

Turnitin and Unizin Partnership Improves Research of Student Writing Performance and Outcomes

With improved data, instructors can provide stronger support for students’ academic progress

July 9, 2018
·
4 min read
Deals

Sandler Capital Funds to Increase Shareholding in BioLife Solutions

Investment Firm to Purchase Shares from Existing Holders

July 9, 2018
·
3 min read
Drug Development

PTC Therapeutics Announces Positive Data from its Translarna™ Phase II Clinical Trial in Children as Young as Two Years with Nonsense Mutation Duchenne Muscular Dystrophy

Translarna is the only approved treatment to address the underlying cause of nmDMD, a rare, genetic, muscle-wasting disease,1 and is currently licensed in Europe for ambulatory patients aged five years and older.3

July 9, 2018
·
11 min read
BioMidwest

New 3M Tegaderm Antimicrobial I.V. Advanced Securement Dressing Helps Make Peripheral Lines a Central Part of Infection Risk Reduction Programs

Every IV catheter poses potential for serious and costly complications, including those occurring from commonly used peripheral intravenous (PIV) catheters.

July 9, 2018
·
3 min read
Biotech Beach

Masimo Announces Vital Signs Check Application for the Root® Patient Monitoring and Connectivity Platform

Masimo announced today the worldwide release of the Vital Signs Check Application, an integrated patient data collection and workflow application for the Masimo Root® patient monitoring and connectivity platform.

July 9, 2018
·
7 min read
Business

Onkos Surgical® and Insight Medical Systems team up to explore applications of augmented reality in musculoskeletal oncology

Insight Medical Systems has teamed up with Onkos Surgical, Inc. to explore opportunities to apply Insight Medical’s ARVIS™

July 9, 2018
·
3 min read
BioMidwest

62% Increase in Plant-based Product Claims, Says Innova Market Insights

Green eating driving plant-based innovation

July 9, 2018
·
3 min read
FDA

FDA Grants Eagle Seven Year Orphan Drug Exclusivity for BENDEKA (bendamustine hydrochloride injection)

Eagle Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted seven years of orphan drug exclusivity (ODE) in the U.S., for BENDEKA™ (bendamustine hydrochloride injection, or bendamustine HCI)

July 9, 2018
·
3 min read
Deals

Bovie Medical Corporation Announces Agreement to Sell “Core” Business Segment to Symmetry Surgical, Inc. for Total Cash Consideration of $97 million

Divestiture and Sale of the Core business segment represents an important strategic transaction that significantly enhances Bovie Medical’s balance sheet and allows the Company to further focus on the commercialization of J-Plasma/Renuvion™ Cosmetic Technology

July 9, 2018
·
8 min read
Deals

Health Enterprise Partners Raises $188 Million in Oversubscribed Third Fund

HEP III will invest in next generation of healthcare information technology and services companies

July 9, 2018
·
4 min read